Showing results (301-310 of 442) with videos related to

Sort By:
Pageof 45
Acta Paediatrica Scandinavica|May 1, 1991
Development of early and late brainstem conduction time in normal and intrauterine growth retarded childrenZ D Jiang, Y Y Wu, M S Zhen, et al.
Pediatric Transplantation|February 1, 2022
Self-reported quality of life in children with ventricular assist devicesDavid M Peng, Sunkyung Yu, Ray Lowery, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 12, 2022
Systemic ventricular assist device support of the Fontan circulation yields promising outcomes: An analysis of The Society of Thoracic Surgeons Pedimacs and Intermacs DatabasesEdo K S Bedzra, Iki Adachi, David M Peng, et al.
Nutritional Neuroscience|September 11, 2008
Duck cerebellum participates in regulation of food intake via the neurotransmitters serotonin and neuropeptide YHua Z Liu, Xin Y Li, Jing J Tong, et al.
Scandinavian Journal of Immunology|March 17, 2009
Activated T cells inhibit NK cell-mediated tumour rejectionX-J Wang, J Hu, J Yuan, et al.
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases|August 5, 2020
[Observation and analysis of lens turbidity lesion induced by low intensity 635 nm laser radiation]Z Ma, X L Dong, Y X Ma, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|January 14, 2020
Right heart failure with left ventricular assist device implantation in children: An analysis of the Pedimacs registry databaseKathleen E Simpson, James K Kirklin, Ryan S Cantor, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|February 16, 2021
Variation in Cardiac Rehabilitation for Pediatric Ventricular Assist Device Recipients Across North AmericaDanielle S Burstein, Michael McBride, Angela Lorts, et al.
Pediatric Transplantation|May 6, 2018
Pathological antibody-mediated rejection in pediatric heart transplant recipients: Immunologic risk factors, hemodynamic significance, and outcomesSeth A Hollander, David M Peng, Marcos Mills, et al.
Anti-Cancer Drugs|June 1, 1992
Phase I and pharmacokinetic study of 502U83 (an arylmethylaminopropanediol) in cancer patientsK S Lam, D S Alberts, Y M Peng, et al.
Pageof 45